Our Advisors

Our collective goal is to champion and advance research for a single purpose: to preserve and restore vision in people with diabetes. Meet our team:

External Scientific Advisory Board

Mark Atkinson, PhD

University of Florida, Director of University of Florida Diabetes Institute; Director, nPOD and CaRe-TID

Sally Baxter, MD

UCSD Shiley Eye Institute, Division Chief for Ophthalmology Informatics and Data Science

Dolly Chang, MD, MPH, PhD

Genentech, Senior Medical Director, Research and Early Development

Sanjoy Dutta, PhD

JDRF, Chief Scientific Officer

Stephen McLeod, MD

American Academy of Ophthalmology, CEO

Tunde Peto, MD, PhD

Queen’s University Belfast, Professor of Clinical Ophthalmology

Marlon Pragnell, PhD

American Diabetes Association, Vice President of Research and Science

Christopher Rhodes, PhD

AstraZeneca Chief Scientist/Vice President, Cardiovascular, Renal and Metabolic Disease, Biopharmaceuticals R&D

José Sahel, MD, PhD

University of Pittsburgh School of Medicine, Chair of Ophthalmology

Marie Schiller

Interim CEO, The Diabetes Link; former VP Drug Development/Device R&D Innovation, Eli Lilly and Company

Don Zack, MD, PhD

Co-Director, Johns Hopkins Center for Stem Cells and Ocular Regenerative Medicine

Lay Advisory Commitee

Chris German, PhD

Senior Scientist, Myriad Genetics | Person with Diabetes

Tom Chapman, MBA

CIO Teewinot Partners | Person with Diabetes

Judy Hunt, MBA

Diabetes Family Advocate

Monica Oxenreiter, MBA, MPP

VP of Close Concerns | Person with Diabetes

Sandra Puczynski, PhD